Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human pentraxin-2

EU orphan designation number: EU/3/12/1020   
Active ingredient: Recombinant human pentraxin-2
Indication: Treatment of idiopathic pulmonary fibrosis
Sponsor: FGK Representative Service GmbH
Heimeranstraße 35, D-80339 München, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/07/2012 Centralised Orphan - Designation EMA/OD/048/12 (2012)5140 of 17/07/2012
17/04/2014 Centralised Orphan - Transfer of orphan designation EMA/OD/048/12/T/01 (2014)2705 of 15/04/2014